Ledger.Open graph →
SEC Form D · filed August 7, 2024

Kate Therapeutics Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Beth Seidenberg, M.D · San Diego, CADirectorKevin Forrest, Ph.D · San Diego, CAExec · DirectorClare Ozawa, Ph.D · San Diego, CADirectorBeth Seidenberg, M.D · San Diego, CADirectorKevin Forrest, Ph.D · San Diego, CAExec · DirectorClare Ozawa, Ph.D · San Diego, CADirectorBenjamin T. Tam · Bristol, United KingdomDirectorMaarten T. Keurst · Abu Dhabi, C0Exec · DirectorShuo Lou · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗